229 related articles for article (PubMed ID: 25696002)
1. NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy.
Takada T; Yamanashi Y; Konishi K; Yamamoto T; Toyoda Y; Masuo Y; Yamamoto H; Suzuki H
Sci Transl Med; 2015 Feb; 7(275):275ra23. PubMed ID: 25696002
[TBL] [Abstract][Full Text] [Related]
2. Niemann-pick C1-like 1 mediates alpha-tocopherol transport.
Narushima K; Takada T; Yamanashi Y; Suzuki H
Mol Pharmacol; 2008 Jul; 74(1):42-9. PubMed ID: 18403720
[TBL] [Abstract][Full Text] [Related]
3. Niemann-Pick C1-like 1 overexpression facilitates ezetimibe-sensitive cholesterol and beta-sitosterol uptake in CaCo-2 cells.
Yamanashi Y; Takada T; Suzuki H
J Pharmacol Exp Ther; 2007 Feb; 320(2):559-64. PubMed ID: 17135346
[TBL] [Abstract][Full Text] [Related]
4. Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.
Davis HR; Altmann SW
Biochim Biophys Acta; 2009 Jul; 1791(7):679-83. PubMed ID: 19272334
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1).
Davis HR; Basso F; Hoos LM; Tetzloff G; Lally SM; Altmann SW
Atheroscler Suppl; 2008 Sep; 9(2):77-81. PubMed ID: 18585981
[TBL] [Abstract][Full Text] [Related]
6. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).
Garcia-Calvo M; Lisnock J; Bull HG; Hawes BE; Burnett DA; Braun MP; Crona JH; Davis HR; Dean DC; Detmers PA; Graziano MP; Hughes M; Macintyre DE; Ogawa A; O'neill KA; Iyer SP; Shevell DE; Smith MM; Tang YS; Makarewicz AM; Ujjainwalla F; Altmann SW; Chapman KT; Thornberry NA
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8132-7. PubMed ID: 15928087
[TBL] [Abstract][Full Text] [Related]
7. Clinical Importance of Drug-Drug Interaction Between Warfarin and Prednisolone and Its Potential Mechanism in Relation to the Niemann-Pick C1-Like 1-Mediated Pathway.
Ito SM; Yamanashi Y; Takada T; Suzuki H
Circ J; 2019 Jan; 83(2):471-480. PubMed ID: 30568065
[TBL] [Abstract][Full Text] [Related]
8. Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane.
Knöpfel M; Davies JP; Duong PT; Kvaernø L; Carreira EM; Phillips MC; Ioannou YA; Hauser H
Biochim Biophys Acta; 2007 Sep; 1771(9):1140-7. PubMed ID: 17689140
[TBL] [Abstract][Full Text] [Related]
9. Respective contributions of intestinal Niemann-Pick C1-like 1 and scavenger receptor class B type I to cholesterol and tocopherol uptake: in vivo v. in vitro studies.
Reboul E; Soayfane Z; Goncalves A; Cantiello M; Bott R; Nauze M; Tercé F; Collet X; Coméra C
Br J Nutr; 2012 May; 107(9):1296-304. PubMed ID: 21929836
[TBL] [Abstract][Full Text] [Related]
10. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.
Altmann SW; Davis HR; Zhu LJ; Yao X; Hoos LM; Tetzloff G; Iyer SP; Maguire M; Golovko A; Zeng M; Wang L; Murgolo N; Graziano MP
Science; 2004 Feb; 303(5661):1201-4. PubMed ID: 14976318
[TBL] [Abstract][Full Text] [Related]
11. The structure and function of Niemann-Pick C1-like 1 protein.
Yu L
Curr Opin Lipidol; 2008 Jun; 19(3):263-9. PubMed ID: 18460917
[TBL] [Abstract][Full Text] [Related]
12. Ezetimibe enhances and stabilizes anticoagulant effect of warfarin.
Hashikata T; Yamaoka-Tojo M; Kakizaki R; Nemoto T; Fujiyoshi K; Namba S; Kitasato L; Hashimoto T; Ishii S; Kameda R; Shimohama T; Tojo T; Ako J
Heart Vessels; 2017 Jan; 32(1):47-54. PubMed ID: 27052207
[TBL] [Abstract][Full Text] [Related]
13. Luteolin and quercetin affect the cholesterol absorption mediated by epithelial cholesterol transporter niemann-pick c1-like 1 in caco-2 cells and rats.
Nekohashi M; Ogawa M; Ogihara T; Nakazawa K; Kato H; Misaka T; Abe K; Kobayashi S
PLoS One; 2014; 9(5):e97901. PubMed ID: 24859282
[TBL] [Abstract][Full Text] [Related]
14. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis.
Davis HR; Zhu LJ; Hoos LM; Tetzloff G; Maguire M; Liu J; Yao X; Iyer SP; Lam MH; Lund EG; Detmers PA; Graziano MP; Altmann SW
J Biol Chem; 2004 Aug; 279(32):33586-92. PubMed ID: 15173162
[TBL] [Abstract][Full Text] [Related]
15. In vivo responsiveness to ezetimibe correlates with niemann-pick C1 like-1 (NPC1L1) binding affinity: Comparison of multiple species NPC1L1 orthologs.
Hawes BE; O'neill KA; Yao X; Crona JH; Davis HR; Graziano MP; Altmann SW
Mol Pharmacol; 2007 Jan; 71(1):19-29. PubMed ID: 17005902
[TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering effects of Coffea arabica pulp aqueous extract in Caco-2 cells and hypercholesterolemic rats.
Ontawong A; Duangjai A; Muanprasat C; Pasachan T; Pongchaidecha A; Amornlerdpison D; Srimaroeng C
Phytomedicine; 2019 Jan; 52():187-197. PubMed ID: 30599898
[TBL] [Abstract][Full Text] [Related]
17. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.
Ge L; Wang J; Qi W; Miao HH; Cao J; Qu YX; Li BL; Song BL
Cell Metab; 2008 Jun; 7(6):508-19. PubMed ID: 18522832
[TBL] [Abstract][Full Text] [Related]
18. Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.
Oswald S; Haenisch S; Fricke C; Sudhop T; Remmler C; Giessmann T; Jedlitschky G; Adam U; Dazert E; Warzok R; Wacke W; Cascorbi I; Kroemer HK; Weitschies W; von Bergmann K; Siegmund W
Clin Pharmacol Ther; 2006 Mar; 79(3):206-17. PubMed ID: 16513445
[TBL] [Abstract][Full Text] [Related]
19. An Approach to Improve Intestinal Absorption of Poorly Absorbed Water-Insoluble Components via Niemann-Pick C1-Like 1.
Takekawa Y; Sato Y; Yamaki Y; Imai M; Noto K; Sumi M; Takekuma Y; Iseki K; Sugawara M
Biol Pharm Bull; 2016; 39(3):301-7. PubMed ID: 26934923
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Expression of Niemann-Pick C1-Like 1, a Cholesterol Reabsorber from Bile, Exacerbates Western Diet-Induced Atherosclerosis in LDL Receptor Mutant Mice.
Yamamoto H; Yamanashi Y; Takada T; Mu S; Tanaka Y; Komine T; Suzuki H
Mol Pharmacol; 2019 Jul; 96(1):47-55. PubMed ID: 31064810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
